Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1992-7-14
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0385-0684
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
909-11
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:1351384-Breast Neoplasms,
pubmed-meshheading:1351384-Female,
pubmed-meshheading:1351384-Humans,
pubmed-meshheading:1351384-Immunoenzyme Techniques,
pubmed-meshheading:1351384-Proto-Oncogene Proteins,
pubmed-meshheading:1351384-Receptor, erbB-2,
pubmed-meshheading:1351384-Tumor Markers, Biological
|
pubmed:year |
1992
|
pubmed:articleTitle |
[C-erb B-2 protein in the sera of breast cancer patients].
|
pubmed:affiliation |
Department of Surgery II, Nagoya University School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article
|